

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 8.57612883 |
| 2 | doxorubicin metabolic process (GO:0044598) | 8.57612883 |
| 3 | daunorubicin metabolic process (GO:0044597) | 8.57612883 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.58281284 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.46757662 |
| 6 | regulation of cilium movement (GO:0003352) | 5.26310850 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.16851306 |
| 8 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.83470584 |
| 9 | rRNA methylation (GO:0031167) | 4.83179502 |
| 10 | rRNA modification (GO:0000154) | 4.82484839 |
| 11 | maintenance of protein location in nucleus (GO:0051457) | 4.78982861 |
| 12 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.77003049 |
| 13 | protein localization to kinetochore (GO:0034501) | 4.74096138 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.66053256 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 4.66053256 |
| 16 | chaperone-mediated protein transport (GO:0072321) | 4.52496804 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 4.44141385 |
| 18 | cullin deneddylation (GO:0010388) | 4.36507986 |
| 19 | ribosome biogenesis (GO:0042254) | 4.35630538 |
| 20 | negative regulation of ligase activity (GO:0051352) | 4.34405371 |
| 21 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.34405371 |
| 22 | rRNA transcription (GO:0009303) | 4.33689005 |
| 23 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.33257259 |
| 24 | DNA replication checkpoint (GO:0000076) | 4.32016495 |
| 25 | proteasome assembly (GO:0043248) | 4.29392220 |
| 26 | oxidative phosphorylation (GO:0006119) | 4.28807273 |
| 27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.27539976 |
| 28 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.25509269 |
| 29 | negative regulation of epidermis development (GO:0045683) | 4.24616925 |
| 30 | negative regulation of telomerase activity (GO:0051974) | 4.19196171 |
| 31 | regulation of mitochondrial translation (GO:0070129) | 4.16884422 |
| 32 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.15252115 |
| 33 | protein complex biogenesis (GO:0070271) | 4.11268207 |
| 34 | DNA deamination (GO:0045006) | 4.10281063 |
| 35 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.07705037 |
| 36 | protein deneddylation (GO:0000338) | 4.07464469 |
| 37 | base-excision repair, AP site formation (GO:0006285) | 4.05882254 |
| 38 | regulation of translation in response to stress (GO:0043555) | 4.05541383 |
| 39 | protein localization to chromosome, centromeric region (GO:0071459) | 4.03176653 |
| 40 | GDP-mannose metabolic process (GO:0019673) | 4.02883844 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.01048540 |
| 42 | respiratory electron transport chain (GO:0022904) | 3.97195186 |
| 43 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.93037525 |
| 44 | mitotic sister chromatid segregation (GO:0000070) | 3.91764871 |
| 45 | protein targeting to mitochondrion (GO:0006626) | 3.91537316 |
| 46 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.90132344 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.86717436 |
| 48 | electron transport chain (GO:0022900) | 3.84835811 |
| 49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83620121 |
| 50 | deoxyribonucleotide catabolic process (GO:0009264) | 3.82195727 |
| 51 | pseudouridine synthesis (GO:0001522) | 3.81447668 |
| 52 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.80225224 |
| 53 | metallo-sulfur cluster assembly (GO:0031163) | 3.77027553 |
| 54 | iron-sulfur cluster assembly (GO:0016226) | 3.77027553 |
| 55 | histone H4-K5 acetylation (GO:0043981) | 3.74034760 |
| 56 | histone H4-K8 acetylation (GO:0043982) | 3.74034760 |
| 57 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.73712631 |
| 58 | negative regulation of telomere maintenance (GO:0032205) | 3.73580101 |
| 59 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.69777771 |
| 60 | deoxyribose phosphate catabolic process (GO:0046386) | 3.69503513 |
| 61 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.68142268 |
| 62 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.68122970 |
| 63 | NADH dehydrogenase complex assembly (GO:0010257) | 3.68122970 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.68122970 |
| 65 | regulation of response to osmotic stress (GO:0047484) | 3.66612381 |
| 66 | establishment of integrated proviral latency (GO:0075713) | 3.63782243 |
| 67 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.63513701 |
| 68 | establishment of protein localization to mitochondrion (GO:0072655) | 3.63506130 |
| 69 | transcription from mitochondrial promoter (GO:0006390) | 3.62919773 |
| 70 | protein maturation by protein folding (GO:0022417) | 3.62595450 |
| 71 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.60129815 |
| 72 | histone H4-K12 acetylation (GO:0043983) | 3.59394370 |
| 73 | positive regulation of ligase activity (GO:0051351) | 3.58126947 |
| 74 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.57167183 |
| 75 | cytochrome complex assembly (GO:0017004) | 3.56660654 |
| 76 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.53614169 |
| 77 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.52602971 |
| 78 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.52602971 |
| 79 | protein localization to mitochondrion (GO:0070585) | 3.52218335 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 3.50386482 |
| 81 | establishment of viral latency (GO:0019043) | 3.49175132 |
| 82 | interferon-gamma production (GO:0032609) | 3.48388057 |
| 83 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.47710672 |
| 84 | DNA strand elongation (GO:0022616) | 3.47615180 |
| 85 | regulation of G0 to G1 transition (GO:0070316) | 3.46318412 |
| 86 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.46246042 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.45717085 |
| 88 | quinone metabolic process (GO:1901661) | 3.45234884 |
| 89 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.44585007 |
| 90 | GTP biosynthetic process (GO:0006183) | 3.43766109 |
| 91 | spliceosomal snRNP assembly (GO:0000387) | 3.43285703 |
| 92 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.41337786 |
| 93 | sequestering of actin monomers (GO:0042989) | 3.38535033 |
| 94 | termination of RNA polymerase III transcription (GO:0006386) | 3.38501151 |
| 95 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.38501151 |
| 96 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.36510633 |
| 97 | regulation of ligase activity (GO:0051340) | 3.32758113 |
| 98 | somite rostral/caudal axis specification (GO:0032525) | 3.32413140 |
| 99 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.31180896 |
| 100 | microtubule severing (GO:0051013) | 3.28432369 |
| 101 | deoxyribose phosphate metabolic process (GO:0019692) | 3.27562641 |
| 102 | cytidine metabolic process (GO:0046087) | 3.26047575 |
| 103 | cytidine catabolic process (GO:0006216) | 3.26047575 |
| 104 | cytidine deamination (GO:0009972) | 3.26047575 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.21617455 |
| 106 | peptidyl-histidine modification (GO:0018202) | 3.21298885 |
| 107 | positive regulation of cell cycle arrest (GO:0071158) | 3.21019731 |
| 108 | UTP biosynthetic process (GO:0006228) | 3.19753100 |
| 109 | negative regulation of protein ubiquitination (GO:0031397) | 3.19064463 |
| 110 | CTP biosynthetic process (GO:0006241) | 3.17973453 |
| 111 | CTP metabolic process (GO:0046036) | 3.17973453 |
| 112 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.17267589 |
| 113 | muscle organ morphogenesis (GO:0048644) | 3.15590999 |
| 114 | purine nucleotide salvage (GO:0032261) | 3.14914596 |
| 115 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.13791172 |
| 116 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.13783935 |
| 117 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.13685874 |
| 118 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.13476262 |
| 119 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.12100982 |
| 120 | purine nucleobase biosynthetic process (GO:0009113) | 3.10844877 |
| 121 | receptor recycling (GO:0001881) | 3.10626236 |
| 122 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.09147025 |
| 123 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06621811 |
| 124 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06621811 |
| 125 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.05818975 |
| 126 | protein polyglutamylation (GO:0018095) | 3.04308408 |
| 127 | ATP biosynthetic process (GO:0006754) | 3.04186853 |
| 128 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.03504395 |
| 129 | deoxyribonucleotide metabolic process (GO:0009262) | 3.03186351 |
| 130 | regulation of cellular amine metabolic process (GO:0033238) | 3.02842226 |
| 131 | negative regulation of B cell apoptotic process (GO:0002903) | 3.02282826 |
| 132 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.02063650 |
| 133 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.00992528 |
| 134 | nucleobase biosynthetic process (GO:0046112) | 2.96849789 |
| 135 | mitochondrial DNA replication (GO:0006264) | 2.94686050 |
| 136 | sister chromatid segregation (GO:0000819) | 2.90858903 |
| 137 | regulation of telomerase activity (GO:0051972) | 2.90699576 |
| 138 | DNA replication initiation (GO:0006270) | 2.89551844 |
| 139 | nucleoside transmembrane transport (GO:1901642) | 2.82353083 |
| 140 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.80436878 |
| 141 | heterochromatin organization (GO:0070828) | 2.77471688 |
| 142 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.75552855 |
| 143 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74459970 |
| 144 | regulation of microtubule-based movement (GO:0060632) | 2.72880862 |
| 145 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.72262844 |
| 146 | cellular component biogenesis (GO:0044085) | 2.70649172 |
| 147 | ribosomal small subunit assembly (GO:0000028) | 2.69160885 |
| 148 | positive regulation of protein deacetylation (GO:0090312) | 2.64584964 |
| 149 | maintenance of protein localization in organelle (GO:0072595) | 2.62238619 |
| 150 | DNA damage response, detection of DNA damage (GO:0042769) | 2.61713054 |
| 151 | histone arginine methylation (GO:0034969) | 2.59438199 |
| 152 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.58578590 |
| 153 | histone H4-K16 acetylation (GO:0043984) | 2.57441256 |
| 154 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.56733170 |
| 155 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.55528821 |
| 156 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.51997136 |
| 157 | seminiferous tubule development (GO:0072520) | 2.51750856 |
| 158 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.50233068 |
| 159 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.49034873 |
| 160 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.49034873 |
| 161 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.47490998 |
| 162 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.47490998 |
| 163 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.47490998 |
| 164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47102353 |
| 165 | apoptotic DNA fragmentation (GO:0006309) | 2.46820879 |
| 166 | transcription from RNA polymerase I promoter (GO:0006360) | 2.44682049 |
| 167 | chromatin assembly (GO:0031497) | 2.43275620 |
| 168 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.42949797 |
| 169 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.42710439 |
| 170 | notochord development (GO:0030903) | 2.42139913 |
| 171 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.39480457 |
| 172 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.39177147 |
| 173 | regulation of double-strand break repair (GO:2000779) | 2.38727194 |
| 174 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.38634707 |
| 175 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.38346723 |
| 176 | mitotic nuclear envelope disassembly (GO:0007077) | 2.38147990 |
| 177 | mitochondrial DNA metabolic process (GO:0032042) | 2.38089671 |
| 178 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.38016761 |
| 179 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.37900817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.82269233 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74138838 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62380165 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.19652881 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.99123373 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.71599940 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.70210608 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.70210608 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.70210608 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.60854769 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51300154 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.44116382 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.36041669 |
| 14 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.33716353 |
| 15 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.30788318 |
| 16 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.29064526 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.24713225 |
| 18 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.17533664 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12953681 |
| 20 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.11073615 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09592006 |
| 22 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.09057152 |
| 23 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.07497468 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.93300708 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89265418 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.86808648 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84519783 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83988190 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.83119019 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.81119062 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80423192 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80370281 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74026085 |
| 34 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.70598818 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.69783032 |
| 36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.68941264 |
| 37 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.68074921 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66993408 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.64625427 |
| 40 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.60806975 |
| 41 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59238012 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56390100 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56353593 |
| 44 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55001212 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52241944 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49812089 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48774673 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.48436233 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43910478 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42706764 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41939888 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41493427 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40610030 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38108805 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36515728 |
| 56 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35973193 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35640963 |
| 58 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.34223456 |
| 59 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32656704 |
| 60 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.31793922 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31671137 |
| 62 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31338016 |
| 63 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30788834 |
| 64 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30288299 |
| 65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29757140 |
| 66 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29362692 |
| 67 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.28622084 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27932809 |
| 69 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27198189 |
| 70 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27108331 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27095568 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25901213 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24924052 |
| 74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23230574 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19672225 |
| 76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19253588 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16396883 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14935831 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.13914430 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12628998 |
| 81 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.12077330 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11857197 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10639663 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10120582 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10093670 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10008509 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09802388 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09704582 |
| 89 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09192121 |
| 90 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08115198 |
| 91 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07926968 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07179204 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06336258 |
| 94 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05779152 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05038764 |
| 96 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.04994644 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03407888 |
| 98 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03331985 |
| 99 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02778948 |
| 100 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02014417 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01196180 |
| 102 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01086116 |
| 103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99749550 |
| 104 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98938873 |
| 105 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.98748776 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98127488 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98075571 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97913444 |
| 109 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97054086 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97003652 |
| 111 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96183167 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96091396 |
| 113 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95836034 |
| 114 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93875496 |
| 115 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92485307 |
| 116 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92462849 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91954676 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91534339 |
| 119 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91444594 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90984652 |
| 121 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90858339 |
| 122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90535067 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 0.89287366 |
| 124 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88415746 |
| 125 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87858406 |
| 126 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87231969 |
| 127 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.86531605 |
| 128 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85513484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.58213866 |
| 2 | MP0003011_delayed_dark_adaptation | 3.37801667 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.33811099 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.18361895 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.12351100 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.73842613 |
| 7 | MP0008260_abnormal_autophagy | 2.72479616 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.59170240 |
| 9 | MP0005499_abnormal_olfactory_system | 2.54457894 |
| 10 | MP0005394_taste/olfaction_phenotype | 2.54457894 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.49985296 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.46832175 |
| 13 | MP0003077_abnormal_cell_cycle | 2.45231904 |
| 14 | MP0008057_abnormal_DNA_replication | 2.33526169 |
| 15 | MP0002822_catalepsy | 2.28213991 |
| 16 | MP0001529_abnormal_vocalization | 2.20173620 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.18785492 |
| 18 | MP0005410_abnormal_fertilization | 2.12796458 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.12549420 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.11066423 |
| 21 | MP0003123_paternal_imprinting | 2.06888174 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 2.06622281 |
| 23 | MP0003122_maternal_imprinting | 2.04621820 |
| 24 | MP0000372_irregular_coat_pigmentation | 2.02201183 |
| 25 | MP0003121_genomic_imprinting | 1.98266636 |
| 26 | MP0008058_abnormal_DNA_repair | 1.91144739 |
| 27 | MP0002254_reproductive_system_inflammat | 1.88986661 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.86723211 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.81503468 |
| 30 | MP0003880_abnormal_central_pattern | 1.80371251 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.76554431 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.76554431 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.75871350 |
| 34 | MP0002163_abnormal_gland_morphology | 1.74772897 |
| 35 | MP0002132_abnormal_respiratory_system | 1.74573017 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.74543830 |
| 37 | MP0004858_abnormal_nervous_system | 1.73445293 |
| 38 | MP0001764_abnormal_homeostasis | 1.60762008 |
| 39 | MP0003718_maternal_effect | 1.60274801 |
| 40 | MP0005380_embryogenesis_phenotype | 1.59835096 |
| 41 | MP0001672_abnormal_embryogenesis/_devel | 1.59835096 |
| 42 | MP0003984_embryonic_growth_retardation | 1.57133247 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.57075974 |
| 44 | MP0005671_abnormal_response_to | 1.56974316 |
| 45 | MP0000490_abnormal_crypts_of | 1.55043494 |
| 46 | MP0002088_abnormal_embryonic_growth/wei | 1.54821533 |
| 47 | MP0005451_abnormal_body_composition | 1.53450106 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.52268459 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.50177291 |
| 50 | MP0000313_abnormal_cell_death | 1.49202701 |
| 51 | MP0000678_abnormal_parathyroid_gland | 1.47052115 |
| 52 | MP0001905_abnormal_dopamine_level | 1.46666443 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.43415116 |
| 54 | MP0006082_CNS_inflammation | 1.38700134 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.38044263 |
| 56 | MP0003786_premature_aging | 1.37150696 |
| 57 | MP0000749_muscle_degeneration | 1.36226556 |
| 58 | MP0001293_anophthalmia | 1.33588608 |
| 59 | MP0002398_abnormal_bone_marrow | 1.33326523 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.32241259 |
| 61 | MP0003787_abnormal_imprinting | 1.30722263 |
| 62 | MP0009785_altered_susceptibility_to | 1.29113540 |
| 63 | MP0002722_abnormal_immune_system | 1.28578254 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 1.28323174 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.27156166 |
| 66 | MP0003186_abnormal_redox_activity | 1.24052272 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.24027070 |
| 68 | MP0005266_abnormal_metabolism | 1.23674808 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.19854909 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 1.19255039 |
| 71 | MP0000358_abnormal_cell_content/ | 1.18919608 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.17441155 |
| 73 | MP0003646_muscle_fatigue | 1.16406856 |
| 74 | MP0001929_abnormal_gametogenesis | 1.16230042 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.15736162 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.15508405 |
| 77 | MP0002429_abnormal_blood_cell | 1.14188676 |
| 78 | MP0001730_embryonic_growth_arrest | 1.13894616 |
| 79 | MP0002019_abnormal_tumor_incidence | 1.10499644 |
| 80 | MP0009697_abnormal_copulation | 1.10115032 |
| 81 | MP0001849_ear_inflammation | 1.09574102 |
| 82 | MP0005330_cardiomyopathy | 1.09101017 |
| 83 | MP0005423_abnormal_somatic_nervous | 1.09099126 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.09096568 |
| 85 | MP0002736_abnormal_nociception_after | 1.05273180 |
| 86 | MP0008932_abnormal_embryonic_tissue | 1.04541902 |
| 87 | MP0000685_abnormal_immune_system | 1.03460534 |
| 88 | MP0000716_abnormal_immune_system | 1.02109171 |
| 89 | MP0002080_prenatal_lethality | 1.01298209 |
| 90 | MP0002269_muscular_atrophy | 1.01189578 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.99318245 |
| 92 | MP0003698_abnormal_male_reproductive | 0.98657835 |
| 93 | MP0001346_abnormal_lacrimal_gland | 0.98361444 |
| 94 | MP0000343_altered_response_to | 0.97814025 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.96035279 |
| 96 | MP0001145_abnormal_male_reproductive | 0.95685469 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.95509359 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.95292003 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.94450930 |
| 100 | MP0001800_abnormal_humoral_immune | 0.94213494 |
| 101 | MP0001697_abnormal_embryo_size | 0.93188444 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.93165139 |
| 103 | MP0002210_abnormal_sex_determination | 0.93117978 |
| 104 | MP0004084_abnormal_cardiac_muscle | 0.93090194 |
| 105 | MP0009278_abnormal_bone_marrow | 0.90135002 |
| 106 | MP0008873_increased_physiological_sensi | 0.90027350 |
| 107 | MP0004147_increased_porphyrin_level | 0.90023217 |
| 108 | MP0002970_abnormal_white_adipose | 0.89897755 |
| 109 | MP0005025_abnormal_response_to | 0.89648031 |
| 110 | MP0003436_decreased_susceptibility_to | 0.87816186 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.87636137 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.87623004 |
| 113 | MP0002405_respiratory_system_inflammati | 0.87240112 |
| 114 | MP0001853_heart_inflammation | 0.85514881 |
| 115 | MP0002420_abnormal_adaptive_immunity | 0.85439685 |
| 116 | MP0001819_abnormal_immune_cell | 0.84083282 |
| 117 | MP0002160_abnormal_reproductive_system | 0.81323688 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.81150981 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.81110478 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.81094096 |
| 121 | MP0000516_abnormal_urinary_system | 0.80369440 |
| 122 | MP0005367_renal/urinary_system_phenotyp | 0.80369440 |
| 123 | MP0002085_abnormal_embryonic_tissue | 0.79899369 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.77516789 |
| 125 | MP0002723_abnormal_immune_serum | 0.76861036 |
| 126 | MP0001968_abnormal_touch/_nociception | 0.76518645 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.76198352 |
| 128 | MP0002735_abnormal_chemical_nociception | 0.75687128 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.73434659 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.73075191 |
| 131 | MP0000049_abnormal_middle_ear | 0.73052223 |
| 132 | MP0001188_hyperpigmentation | 0.73051633 |
| 133 | MP0009672_abnormal_birth_weight | 0.73032663 |
| 134 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72830746 |
| 135 | MP0000858_altered_metastatic_potential | 0.72825688 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.71472374 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.69190821 |
| 138 | MP0005379_endocrine/exocrine_gland_phen | 0.68414640 |
| 139 | MP0004859_abnormal_synaptic_plasticity | 0.66549295 |
| 140 | MP0002102_abnormal_ear_morphology | 0.65440460 |
| 141 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65121906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Multiple enchondromatosis (HP:0005701) | 5.30213866 |
| 2 | Bilateral microphthalmos (HP:0007633) | 5.28485860 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.27130594 |
| 4 | Hepatocellular necrosis (HP:0001404) | 5.12467327 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 5.11945407 |
| 6 | Mitochondrial inheritance (HP:0001427) | 5.02553984 |
| 7 | Hepatic necrosis (HP:0002605) | 4.63638414 |
| 8 | Acute encephalopathy (HP:0006846) | 4.54183074 |
| 9 | Increased CSF lactate (HP:0002490) | 4.49961820 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.49738413 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.49738413 |
| 12 | Abnormality of the lower motor neuron (HP:0002366) | 4.40578200 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 4.33737215 |
| 14 | Progressive macrocephaly (HP:0004481) | 4.08227414 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 3.98759537 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 3.83664662 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.82815720 |
| 18 | Ragged-red muscle fibers (HP:0003200) | 3.78006341 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.71532536 |
| 20 | Hepatoblastoma (HP:0002884) | 3.55968803 |
| 21 | Lactic acidosis (HP:0003128) | 3.55745509 |
| 22 | Renal Fanconi syndrome (HP:0001994) | 3.55304181 |
| 23 | Nasal polyposis (HP:0100582) | 3.51269134 |
| 24 | Aplastic anemia (HP:0001915) | 3.49456119 |
| 25 | Impulsivity (HP:0100710) | 3.48525197 |
| 26 | Exercise intolerance (HP:0003546) | 3.47456629 |
| 27 | Cerebral edema (HP:0002181) | 3.40247082 |
| 28 | Increased serum lactate (HP:0002151) | 3.36836353 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 3.36631681 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 3.25374547 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 3.24805633 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 3.20934058 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19956056 |
| 34 | Respiratory failure (HP:0002878) | 3.15285500 |
| 35 | Progressive muscle weakness (HP:0003323) | 3.13577164 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.12605177 |
| 37 | Ependymoma (HP:0002888) | 3.09360619 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 3.05987782 |
| 39 | Microretrognathia (HP:0000308) | 3.04525789 |
| 40 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.01952141 |
| 41 | Tongue fasciculations (HP:0001308) | 2.85611159 |
| 42 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.85376226 |
| 43 | Respiratory difficulties (HP:0002880) | 2.82017616 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.81382379 |
| 45 | Trismus (HP:0000211) | 2.80827721 |
| 46 | Rib fusion (HP:0000902) | 2.79896552 |
| 47 | Cholecystitis (HP:0001082) | 2.78368268 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.78368268 |
| 49 | Exertional dyspnea (HP:0002875) | 2.77239535 |
| 50 | Hypoplasia of the fovea (HP:0007750) | 2.75651013 |
| 51 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.75651013 |
| 52 | Abnormal lung lobation (HP:0002101) | 2.74814269 |
| 53 | Emotional lability (HP:0000712) | 2.74614642 |
| 54 | Rhabdomyosarcoma (HP:0002859) | 2.74180551 |
| 55 | Chromsome breakage (HP:0040012) | 2.73264376 |
| 56 | Meckel diverticulum (HP:0002245) | 2.71356204 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.70967089 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.70967089 |
| 59 | Muscle fibrillation (HP:0010546) | 2.62406096 |
| 60 | Embryonal renal neoplasm (HP:0011794) | 2.61728521 |
| 61 | Neoplasm of striated muscle (HP:0009728) | 2.59300393 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.58851213 |
| 63 | Myelodysplasia (HP:0002863) | 2.56975078 |
| 64 | Leukodystrophy (HP:0002415) | 2.56184473 |
| 65 | Abnormality of the ileum (HP:0001549) | 2.55007718 |
| 66 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.52974266 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51539344 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.51539344 |
| 69 | Rough bone trabeculation (HP:0100670) | 2.49452352 |
| 70 | Pancytopenia (HP:0001876) | 2.49064685 |
| 71 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47981415 |
| 72 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.47686035 |
| 73 | Testicular atrophy (HP:0000029) | 2.45772754 |
| 74 | Supernumerary spleens (HP:0009799) | 2.40839960 |
| 75 | Tetraplegia (HP:0002445) | 2.35168817 |
| 76 | Premature ovarian failure (HP:0008209) | 2.35063561 |
| 77 | Facial cleft (HP:0002006) | 2.34766977 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33858140 |
| 79 | Combined immunodeficiency (HP:0005387) | 2.31296938 |
| 80 | Gout (HP:0001997) | 2.30356479 |
| 81 | CNS demyelination (HP:0007305) | 2.29609992 |
| 82 | Petechiae (HP:0000967) | 2.26518693 |
| 83 | Agammaglobulinemia (HP:0004432) | 2.26496126 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.25089559 |
| 85 | Small intestinal stenosis (HP:0012848) | 2.24570652 |
| 86 | Duodenal stenosis (HP:0100867) | 2.24570652 |
| 87 | Opisthotonus (HP:0002179) | 2.22549314 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.21541724 |
| 89 | Abnormality of the motor neurons (HP:0002450) | 2.21350900 |
| 90 | Abnormal neuron morphology (HP:0012757) | 2.21350900 |
| 91 | Increased serum pyruvate (HP:0003542) | 2.21211455 |
| 92 | Abnormality of glycolysis (HP:0004366) | 2.21211455 |
| 93 | Colon cancer (HP:0003003) | 2.20295152 |
| 94 | Abnormality of the fovea (HP:0000493) | 2.18251595 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 2.16448587 |
| 96 | Cerebral hypomyelination (HP:0006808) | 2.16050895 |
| 97 | Pendular nystagmus (HP:0012043) | 2.15233188 |
| 98 | Delusions (HP:0000746) | 2.14819105 |
| 99 | Hypochromic anemia (HP:0001931) | 2.14759933 |
| 100 | Rectal fistula (HP:0100590) | 2.14400512 |
| 101 | Rectovaginal fistula (HP:0000143) | 2.14400512 |
| 102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12920163 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 2.12635861 |
| 104 | Sparse eyelashes (HP:0000653) | 2.12464547 |
| 105 | Muscle fiber atrophy (HP:0100295) | 2.12066899 |
| 106 | Preauricular skin tag (HP:0000384) | 2.11269641 |
| 107 | Myositis (HP:0100614) | 2.10865706 |
| 108 | Hyperventilation (HP:0002883) | 2.10019815 |
| 109 | Double outlet right ventricle (HP:0001719) | 2.09412842 |
| 110 | Congenital malformation of the right heart (HP:0011723) | 2.09412842 |
| 111 | Abnormality of the labia minora (HP:0012880) | 2.09272781 |
| 112 | Cleft eyelid (HP:0000625) | 2.08668186 |
| 113 | Sloping forehead (HP:0000340) | 2.08096632 |
| 114 | Abnormality of the preputium (HP:0100587) | 2.07135374 |
| 115 | Lethargy (HP:0001254) | 2.06609461 |
| 116 | Generalized hypotonia (HP:0001290) | 2.05771162 |
| 117 | Bone marrow hypocellularity (HP:0005528) | 2.05663111 |
| 118 | Bifid tongue (HP:0010297) | 2.05530234 |
| 119 | Progressive microcephaly (HP:0000253) | 2.02854576 |
| 120 | Reticulocytopenia (HP:0001896) | 2.01938917 |
| 121 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01685683 |
| 122 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01685683 |
| 123 | Abnormal protein glycosylation (HP:0012346) | 2.01685683 |
| 124 | Abnormal glycosylation (HP:0012345) | 2.01685683 |
| 125 | Obstructive lung disease (HP:0006536) | 2.01352671 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01352671 |
| 127 | Short 5th finger (HP:0009237) | 2.00601307 |
| 128 | Partial duplication of thumb phalanx (HP:0009944) | 1.99261663 |
| 129 | Optic disc pallor (HP:0000543) | 1.99017763 |
| 130 | Cerebral palsy (HP:0100021) | 1.98835050 |
| 131 | Intestinal fistula (HP:0100819) | 1.98478863 |
| 132 | CNS hypomyelination (HP:0003429) | 1.98412293 |
| 133 | Severe global developmental delay (HP:0011344) | 1.97866935 |
| 134 | Horizontal nystagmus (HP:0000666) | 1.97192070 |
| 135 | Type 2 muscle fiber atrophy (HP:0003554) | 1.96379222 |
| 136 | Thrombocytosis (HP:0001894) | 1.94367090 |
| 137 | Cholelithiasis (HP:0001081) | 1.94220003 |
| 138 | Orchitis (HP:0100796) | 1.93105349 |
| 139 | Upper motor neuron abnormality (HP:0002127) | 1.92707092 |
| 140 | Myopathic facies (HP:0002058) | 1.92593015 |
| 141 | Vaginal fistula (HP:0004320) | 1.92426559 |
| 142 | Poor head control (HP:0002421) | 1.91820574 |
| 143 | Gliosis (HP:0002171) | 1.90855461 |
| 144 | Neoplasm of the adrenal gland (HP:0100631) | 1.90655219 |
| 145 | Abnormality of the salivary glands (HP:0010286) | 1.89053555 |
| 146 | Progressive external ophthalmoplegia (HP:0000590) | 1.84087817 |
| 147 | Carpal bone hypoplasia (HP:0001498) | 1.83488962 |
| 148 | Rhabdomyolysis (HP:0003201) | 1.82403658 |
| 149 | X-linked dominant inheritance (HP:0001423) | 1.82211943 |
| 150 | Skin tags (HP:0010609) | 1.81181302 |
| 151 | Macrocytic anemia (HP:0001972) | 1.81022319 |
| 152 | IgM deficiency (HP:0002850) | 1.79606235 |
| 153 | Broad foot (HP:0001769) | 1.78846433 |
| 154 | Spastic paraparesis (HP:0002313) | 1.78636951 |
| 155 | Abnormal pupillary function (HP:0007686) | 1.78063394 |
| 156 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77399854 |
| 157 | Abnormal number of erythroid precursors (HP:0012131) | 1.76664829 |
| 158 | Abnormal gallbladder morphology (HP:0012437) | 1.76565284 |
| 159 | Exercise-induced muscle cramps (HP:0003710) | 1.75706566 |
| 160 | Single umbilical artery (HP:0001195) | 1.74901626 |
| 161 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.74901626 |
| 162 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.74901626 |
| 163 | Abnormality of renal resorption (HP:0011038) | 1.72598621 |
| 164 | Broad distal phalanx of finger (HP:0009836) | 1.72449870 |
| 165 | Secondary amenorrhea (HP:0000869) | 1.71841799 |
| 166 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71839371 |
| 167 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71839371 |
| 168 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71839371 |
| 169 | Hypertensive crisis (HP:0100735) | 1.71228353 |
| 170 | Hypoplastic left heart (HP:0004383) | 1.70789459 |
| 171 | Nausea (HP:0002018) | 1.70131933 |
| 172 | Methylmalonic acidemia (HP:0002912) | 1.68263303 |
| 173 | Abnormality of lateral ventricle (HP:0030047) | 1.67721028 |
| 174 | Hepatosplenomegaly (HP:0001433) | 1.66919479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.95342576 |
| 2 | CDK12 | 5.45747042 |
| 3 | ERN1 | 3.97383955 |
| 4 | GRK5 | 3.85446335 |
| 5 | BUB1 | 3.25492640 |
| 6 | GRK6 | 3.13967379 |
| 7 | ADRBK2 | 2.72669366 |
| 8 | CSF1R | 2.65558731 |
| 9 | SMG1 | 2.29412643 |
| 10 | TGFBR2 | 2.26772074 |
| 11 | PDK4 | 2.25921874 |
| 12 | PDK3 | 2.25921874 |
| 13 | PBK | 2.18774323 |
| 14 | TAF1 | 2.15432024 |
| 15 | GRK1 | 2.03077497 |
| 16 | MATK | 2.02707178 |
| 17 | WEE1 | 1.89667282 |
| 18 | TTK | 1.80911866 |
| 19 | CSNK1G3 | 1.75628595 |
| 20 | MAPK7 | 1.72057549 |
| 21 | NUAK1 | 1.67398240 |
| 22 | NME1 | 1.63053488 |
| 23 | CCNB1 | 1.62499885 |
| 24 | NEK1 | 1.61685489 |
| 25 | MAP3K11 | 1.61212631 |
| 26 | ZAK | 1.55856275 |
| 27 | NEK2 | 1.52820755 |
| 28 | CDK7 | 1.48636222 |
| 29 | CDK19 | 1.45330010 |
| 30 | STK10 | 1.44475021 |
| 31 | TESK1 | 1.42726810 |
| 32 | EIF2AK1 | 1.42232085 |
| 33 | PLK4 | 1.42106559 |
| 34 | MOS | 1.41256397 |
| 35 | PAK4 | 1.39603030 |
| 36 | DYRK2 | 1.37980848 |
| 37 | LIMK1 | 1.37921190 |
| 38 | PLK1 | 1.35140672 |
| 39 | AKT3 | 1.34056609 |
| 40 | GRK7 | 1.32373384 |
| 41 | MAP2K6 | 1.31841063 |
| 42 | CSNK1A1L | 1.31742400 |
| 43 | TRIM28 | 1.31326981 |
| 44 | CSNK1G2 | 1.31095869 |
| 45 | STK16 | 1.29061631 |
| 46 | SIK3 | 1.27801818 |
| 47 | PRKG2 | 1.23679576 |
| 48 | NME2 | 1.23352280 |
| 49 | TESK2 | 1.22546595 |
| 50 | MST4 | 1.21629842 |
| 51 | CSNK1G1 | 1.19295651 |
| 52 | PLK3 | 1.16751454 |
| 53 | MAP4K2 | 1.14664926 |
| 54 | PIM2 | 1.12158381 |
| 55 | CAMK4 | 1.10632422 |
| 56 | PDK2 | 1.09390121 |
| 57 | CHEK2 | 1.09349666 |
| 58 | KIT | 1.03767337 |
| 59 | ABL2 | 1.02869172 |
| 60 | BCKDK | 1.01474161 |
| 61 | BRSK2 | 0.98749803 |
| 62 | ZAP70 | 0.95779233 |
| 63 | DYRK3 | 0.95290366 |
| 64 | CDK8 | 0.95237354 |
| 65 | PRKD3 | 0.95197315 |
| 66 | TSSK6 | 0.94078011 |
| 67 | MAP4K1 | 0.93041130 |
| 68 | MAPKAPK3 | 0.92984688 |
| 69 | TAOK2 | 0.90465897 |
| 70 | TYRO3 | 0.89750730 |
| 71 | DAPK3 | 0.85805225 |
| 72 | BRSK1 | 0.85481483 |
| 73 | ARAF | 0.85402207 |
| 74 | TNK2 | 0.83557382 |
| 75 | DAPK1 | 0.82980815 |
| 76 | MAP2K3 | 0.82563111 |
| 77 | MUSK | 0.79932273 |
| 78 | MAP2K7 | 0.78898315 |
| 79 | MAP2K4 | 0.75074972 |
| 80 | TAOK1 | 0.74016852 |
| 81 | STK4 | 0.70748057 |
| 82 | IKBKB | 0.68732151 |
| 83 | LRRK2 | 0.67623481 |
| 84 | MAP3K12 | 0.66914760 |
| 85 | FGFR3 | 0.66667718 |
| 86 | ACVR1B | 0.66550610 |
| 87 | MARK2 | 0.63996739 |
| 88 | CDK14 | 0.62997050 |
| 89 | RPS6KA5 | 0.62369178 |
| 90 | CDK11A | 0.62285254 |
| 91 | TLK1 | 0.62099754 |
| 92 | CHEK1 | 0.61143948 |
| 93 | SRPK1 | 0.59261859 |
| 94 | IRAK3 | 0.59197979 |
| 95 | ADRBK1 | 0.58857940 |
| 96 | MAP3K8 | 0.58281266 |
| 97 | CDK18 | 0.57602560 |
| 98 | CDK15 | 0.57214857 |
| 99 | CSNK2A1 | 0.56907939 |
| 100 | TXK | 0.56537468 |
| 101 | KDR | 0.56379438 |
| 102 | AKT2 | 0.55769066 |
| 103 | HIPK2 | 0.54525703 |
| 104 | CSNK2A2 | 0.54368466 |
| 105 | CDC7 | 0.52892731 |
| 106 | CDK4 | 0.52685904 |
| 107 | IRAK4 | 0.52290344 |
| 108 | PINK1 | 0.51769897 |
| 109 | EIF2AK3 | 0.51567666 |
| 110 | AURKA | 0.51281980 |
| 111 | ALK | 0.51232644 |
| 112 | SCYL2 | 0.51066552 |
| 113 | MAP3K10 | 0.50170072 |
| 114 | RPS6KB2 | 0.48299856 |
| 115 | WNK1 | 0.48040631 |
| 116 | EIF2AK2 | 0.47397044 |
| 117 | AURKB | 0.47337008 |
| 118 | FES | 0.46378632 |
| 119 | IRAK2 | 0.46292506 |
| 120 | TIE1 | 0.46166271 |
| 121 | MYLK | 0.45969364 |
| 122 | ILK | 0.45196309 |
| 123 | PRKCI | 0.44350998 |
| 124 | PIM1 | 0.44282396 |
| 125 | MINK1 | 0.43799357 |
| 126 | ATR | 0.43573030 |
| 127 | MAP3K7 | 0.42742039 |
| 128 | VRK1 | 0.42353718 |
| 129 | BLK | 0.41791325 |
| 130 | ERBB3 | 0.41549263 |
| 131 | SYK | 0.41030668 |
| 132 | MAPK12 | 0.40657711 |
| 133 | BRAF | 0.39615589 |
| 134 | CAMKK2 | 0.39286419 |
| 135 | MAPKAPK5 | 0.37858457 |
| 136 | FLT3 | 0.36802997 |
| 137 | MAPK4 | 0.36533080 |
| 138 | PAK1 | 0.36142494 |
| 139 | BTK | 0.35153364 |
| 140 | RPS6KA4 | 0.34843506 |
| 141 | TBK1 | 0.33144407 |
| 142 | EPHA4 | 0.33143708 |
| 143 | CDK2 | 0.31757732 |
| 144 | CHUK | 0.31341998 |
| 145 | BMPR2 | 0.30981591 |
| 146 | PAK6 | 0.28415486 |
| 147 | TYK2 | 0.26217883 |
| 148 | MAPK11 | 0.26095517 |
| 149 | LYN | 0.25496675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.50220629 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.06824511 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.58369412 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.22974817 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.13681066 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.78165865 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.68513841 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.53006797 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.45267223 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.28065484 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.25509372 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.22992313 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.21361826 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08775268 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.06225635 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02891933 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.96048897 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.94401151 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.85337962 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.76967564 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.73376164 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.68703213 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.66738310 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.65604405 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.63600863 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.63403846 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50648094 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.50218955 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.46097760 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.45548210 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45355315 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44768860 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.40404377 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39096340 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37534014 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33258797 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32337284 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30612570 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29575260 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.28281483 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26462425 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20441259 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20398370 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20155149 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19106625 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18668619 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11633516 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09155041 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07620530 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02246699 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01340029 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01032841 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99035114 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93925028 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91886445 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90958029 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90851194 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89892503 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89543111 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84227425 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83842351 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83566164 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80999871 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.79655857 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77357082 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75799977 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74669198 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73982007 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71989490 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71965093 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.70322344 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.67549958 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64585996 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63819270 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61956467 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61497311 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61200163 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.59185481 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57689379 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57066634 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57029743 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56433123 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56311459 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.55331810 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54774772 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54733597 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54349677 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54131360 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53848800 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52960128 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.52200121 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51775878 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49206137 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49154559 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48475528 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47246119 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44764984 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43410782 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42422756 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40388592 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37556649 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36897116 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.36840399 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36800949 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35247078 |
| 106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35068211 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34149777 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33723129 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33134723 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31157934 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30529592 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.30474240 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29913478 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28996508 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27682293 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27167040 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26529234 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.24575050 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23897421 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23886454 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22025707 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21948815 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17090009 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.15674647 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15196002 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14414402 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14272091 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14211240 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14130820 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.13805044 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13377245 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12677933 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12631654 |
| 134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.12364211 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.11512573 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.10985073 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.10452551 |
| 138 | Parkinsons disease_Homo sapiens_hsa05012 | 0.09326530 |

